Gastric/GE Junction Cancer – Howard Hochster, MD, and Robert Figlin, MD, discuss clinical highlights from ASCO 2019

Gastric/GE Junction Cancer – Howard Hochster, MD, and Robert Figlin, MD, discuss clinical highlights from ASCO 2019

Friday June 21, 2019

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Howard Hochster, MD, Professor of Medicine Associate Director for Clinical Research and Director, GI Oncology, Rutgers Cancer Institute, discuss gastric/GE junction cancer clinical highlights from ASCO 2019.

Featured Videos

Banu Arun, MD, on PARP inhibitors in BRCA positive metastatic breast cancer

Joyce O’Shaughnessy, MD, on the role of CDK4/6 inhibitors in the management of TNBC

Véronique Diéras, MD, on BRCA-positive metastatic breast cancer & PARP inhibitors